|
GB227835A
(en)
|
1924-01-15 |
1925-04-09 |
Harry Odell |
Improvements in feeding mechanism for embossing and other printing presses
|
|
JPS58116498A
(ja)
|
1981-12-28 |
1983-07-11 |
Takeda Chem Ind Ltd |
Ｉｌ‐２をコードする新規伝令ｒｎａの製造法
|
|
DE3377363D1
(en)
|
1982-03-31 |
1988-08-18 |
Ajinomoto Kk |
Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
|
|
US4518584A
(en)
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
|
US4752585A
(en)
|
1985-12-17 |
1988-06-21 |
Cetus Corporation |
Oxidation-resistant muteins
|
|
JPH01196296A
(ja)
*
|
1988-01-29 |
1989-08-08 |
Toray Ind Inc |
動物細胞用発現ベクター
|
|
US4919918A
(en)
|
1988-03-14 |
1990-04-24 |
Spectrum Consumer Products Co., Inc. |
Non-alcoholic mouthwash
|
|
US5972685A
(en)
|
1988-07-21 |
1999-10-26 |
Iowa State University Research Foundation, Inc. |
Oral administration of coprostanol producing microorganisms to humans to decrease plasma cholesterol concentration
|
|
GB9006400D0
(en)
|
1990-03-22 |
1990-05-23 |
Ciba Geigy Ag |
Bacterial vectors
|
|
US6221840B1
(en)
|
1991-02-14 |
2001-04-24 |
The General Hospital Corporation |
Intestinal trefoil proteins
|
|
DE69232619T2
(de)
|
1991-02-14 |
2002-09-12 |
The General Hospital Corp., Charlestown |
Intestinale kleeblatt-proteine
|
|
US6277969B1
(en)
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
GB9126306D0
(en)
|
1991-12-11 |
1992-02-12 |
Unilever Plc |
Mouthwash compositions
|
|
WO1993017117A1
(en)
|
1992-02-27 |
1993-09-02 |
Lynxvale Limited |
Heterologous gene expression in lactococcus, and the expression products therefrom
|
|
US5223285A
(en)
|
1992-03-31 |
1993-06-29 |
Abbott Laboratories |
Nutritional product for pulmonary patients
|
|
EP0569604A1
(en)
|
1992-04-07 |
1993-11-18 |
Societe Des Produits Nestle S.A. |
Integrative gene-expression in Streptococcus salivarius ssp.thermophilus
|
|
US5229109A
(en)
|
1992-04-14 |
1993-07-20 |
Board Of Regents, The University Of Texas System |
Low toxicity interleukin-2 analogues for use in immunotherapy
|
|
US5700782A
(en)
|
1993-05-28 |
1997-12-23 |
Abbott Laboratories |
Enteral nutritional product
|
|
WO1996032486A1
(en)
|
1995-04-11 |
1996-10-17 |
Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno |
Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface
|
|
US5695746A
(en)
|
1995-07-28 |
1997-12-09 |
Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. |
Liquid dentifrice with mouthwash fresh taste
|
|
GB9521568D0
(en)
|
1995-10-20 |
1995-12-20 |
Lynxvale Ltd |
Delivery of biologically active polypeptides
|
|
WO1997026855A1
(en)
|
1996-01-24 |
1997-07-31 |
Warner-Lambert Company |
Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems
|
|
GB9611364D0
(en)
|
1996-05-31 |
1996-08-07 |
Smithkline Beecham Plc |
Composition
|
|
US5993785A
(en)
|
1996-09-18 |
1999-11-30 |
Erling Johansen |
Mouthwash compositions
|
|
US5869118A
(en)
|
1996-11-13 |
1999-02-09 |
Abbott Laboratories |
Gellan gum to improve physical stability of liquid nutritional products
|
|
US6171611B1
(en)
|
1997-11-12 |
2001-01-09 |
Dante J. Picciano |
Iodine-containing nasal moisturizing saline and mouthwash solutions
|
|
US5897872A
(en)
|
1997-11-12 |
1999-04-27 |
Picciano; Dante J. |
Iodine-containing nasal moisturizing saline solution
|
|
MXPA01003197A
(es)
|
1998-09-28 |
2004-04-21 |
Warner Lambert Co |
Suministro enterico y colonico utilizando capsulas de chpm.
|
|
WO2000022909A2
(en)
|
1998-10-19 |
2000-04-27 |
Biotech Australia Pty. Limited |
Systems for oral delivery
|
|
DE69914932T2
(de)
|
1998-10-20 |
2004-12-09 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. |
Verwendung eines zytokine-produzierenden lactococcus stammes zur behandlung von kolitis
|
|
BR0012632A
(pt)
|
1999-06-30 |
2002-06-04 |
Produites Nestle S A Soc D |
Operon de lactose de lactobacillus delbrueckii e uso do mesmo para controlar a transcrição eiou expressão de gene em células bacterianas
|
|
PT1739178E
(pt)
|
1999-07-05 |
2010-11-17 |
Actogenix Nv |
Libertação de péptidos trifólios
|
|
AU2001238582A1
(en)
*
|
2000-02-24 |
2001-09-03 |
Siga Pharmaceuticals, Inc |
Intergenic and intragenic integration sites for foreign gene expression in recombinant s. gordonii strains
|
|
US7029842B2
(en)
*
|
2000-04-07 |
2006-04-18 |
Novozymes A/S |
Signal sequence trapping
|
|
GB0013810D0
(en)
|
2000-06-06 |
2000-07-26 |
Celltech Chiroscience Ltd |
Biological products
|
|
DK1383897T3
(da)
|
2001-05-03 |
2006-10-30 |
Vlaams Interuniv Inst Biotech |
Selv-containing Lactococcus-stamme
|
|
EP1319410A1
(en)
*
|
2001-12-11 |
2003-06-18 |
Société des Produits Nestlé S.A. |
Use of micro-organisms for a directed delivery of substances to specific parts of the gut
|
|
EP1536749A2
(en)
|
2002-07-08 |
2005-06-08 |
Joe S. Wilkins, Jr. |
Antibacterial formulations
|
|
AU2003298291A1
(en)
|
2002-11-15 |
2004-06-15 |
Universiteit Gent |
Self-containing lactobacillus strain
|
|
WO2004069177A2
(en)
|
2003-01-31 |
2004-08-19 |
The Trustees Of The University Of Pennsylvania |
Methods for modulating an inflammatory response
|
|
EP1493816A1
(en)
*
|
2003-07-02 |
2005-01-05 |
Friesland Brands B.V. |
Methods and means for regulating gene expression
|
|
US7569215B2
(en)
|
2003-07-18 |
2009-08-04 |
Massachusetts Institute Of Technology |
Mutant interleukin-2 (IL-2) polypeptides
|
|
US7842289B2
(en)
*
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
|
EP1708741B1
(en)
*
|
2003-12-24 |
2016-03-30 |
Aduro Biotech |
Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
|
|
US20060234205A1
(en)
|
2004-03-05 |
2006-10-19 |
Chiron Corporation |
In vitro test system for predicting patient tolerability of therapeutic agents
|
|
US7495092B2
(en)
*
|
2005-01-14 |
2009-02-24 |
North Carolina State University |
Compositions comprising promoter sequences and methods of use
|
|
US7764366B2
(en)
|
2006-07-11 |
2010-07-27 |
Besi North America, Inc. |
Robotic die sorter with optical inspection system
|
|
JP2009544679A
(ja)
*
|
2006-07-25 |
2009-12-17 |
ザ ユニヴァーシティー コート オブ ザ ユニヴァーシティー オブ ダンディー |
異常な細胞増殖に関連する疾患の治療におけるレチノイド及び小分子のＮｒｆ２アンタゴニストとしての使用
|
|
AU2008204442B2
(en)
*
|
2007-01-12 |
2013-03-14 |
Intrexon Actobiotics Nv |
Lactococcus promoters and uses thereof
|
|
CA2760248C
(en)
|
2009-04-30 |
2019-05-28 |
Actogenix Nv |
Cryoprotectants for freeze drying of lactic acid bacteria
|
|
SG192673A1
(en)
|
2011-02-10 |
2013-09-30 |
Roche Glycart Ag |
Mutant interleukin-2 polypeptides
|
|
BR112013023151A2
(pt)
|
2011-03-11 |
2020-09-15 |
Assistance Publique - Hôpitaux De Paris |
interleucina-2 para uso no tratamento de desordem auto-imune, !muno-relacionada ou inflamatória e método para determinar se um regime ou dose de il-2 tem de ser modificado
|
|
WO2012164083A1
(en)
|
2011-06-01 |
2012-12-06 |
Actogenix N.V. |
Polycistronic expression system for bacteria
|
|
WO2013036914A1
(en)
|
2011-09-08 |
2013-03-14 |
University Of Florida Research Foundation, Inc. |
Materials and methods for modulating immune responses
|
|
US10905727B2
(en)
|
2016-01-14 |
2021-02-02 |
Intrexon Actobiotics N.V. |
Compositions and methods for the treatment of type 1 diabetes
|